Erythropoietin suppresses peritoneal fibrosis in rat experimental model

European Journal of Pharmacology

Volumn 604, Issue 1-3, 2009, Pages 138-149

  Mondello, Stefania ^a   Mazzon, Emanuela ^b   Di Paola, Rosanna ^b   Crisafulli, Concetta ^a   Italiano, Domenico ^a   Buemi, Michele ^a   Aloisi, Calmela ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Erythropoietin (EPO); Oxidative stress; Peritoneal dialysis; Peritoneal fibrosis

Indexed keywords

ERYTHROPOIETIN; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CHLORHEXIDINE; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FIBROSIS; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; RATS; RATS, INBRED STRAINS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 58949095604     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.039     Document Type: Article

References (55)

1. Agarwal S., Deschner J., Long P., Verma A., Hofman C., Evans C.H., and Piesco N. Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals. Arthritis Rheum. 50 (2004) 3541-3548
2. Agnello D., Bigini P., Villa P., Mennini T., Cerami A., Brines M.L., and Ghezzi P. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952 (2002) 128-134
3. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9 (1996) 836-844
4. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., and Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18 (1998) 3251-3260
5. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342 (2000) 1350-1358
6. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59 (2000) 13-23
7. Bunke C.M., Brier M.E., and Golper T.A. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int. 52 (1997) 524-529
8. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., and Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 425 (2007) 177-182
9. Coles G.A., and Topley N. Long-term peritoneal membrane changes. Adv. Renal Replace. Ther. 7 (2000) 289-301
10. Combet S., Van Landschoot M., Moulin P., Piech A., Verbavatz J.M., Goffin E., Balligand J.L., Lameire N., and Devuyst O. Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J. Am. Soc. Nephrol. 10 (1999) 2185-2196
11. Cuzzocrea S., Mazzon E., Di Paola R., Patel N.S., Genovese T., Muia C., De Sarro A., and Thiemermann C. Erythropoietin reduces the development of experimental inflammatory bowel disease. J. Pharmacol. Exp. Ther. 311 (2004) 1272-1280
12. Cuzzocrea S., Thiemermann C., and Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr. Med. Chem. 11 (2004) 1147-1162
13. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Patel N.S., Britti D., de Majo M., Caputi A.P., and Thiemermann C. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Arthritis Rheum. 52 (2005) 940-950
14. Cuzzocrea S., Genovese T., Mazzon E., Crisafulli C., Min W., Di Paola R., Muia C., Li J.H., Esposito E., Bramanti P., Xu W., Massuda E., Zhang J., and Wang Z.Q. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma. J. Pharmacol. Exp. Ther. 319 (2006) 127-138
15. Davies S.J., Phillips L., Griffiths A.M., Russell L.H., Naish P.F., and Russell G.I. What really happens to people on long-term peritoneal dialysis?. Kidney Int. 54 (1998) 2207-2217
16. De Muro P., Faedda R., Fresu P., Masala A., Cigni A., Concas G., Mela M.G., Satta A., Carcassi A., Sanna G.M., and Cherchi G.M. Urinary transforming growth factor-beta 1 in various types of nephropathy. Pharmacol. Res. 49 (2004) 293-298
17. Douma C.E., de Waart D.R., Struijk D.G., and Krediet R.T. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int. 51 (1997) 1885-1892
18. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391 (1998) 393-397
19. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
20. Gandhi V.C., Humayun H.M., Ing T.S., Daugirdas J.T., Jablokow V.R., Iwatsuki S., Geis W.P., and Hano J.E. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch. Intern. Med. 140 (1980) 1201-1203
21. Giraudo E., Primo L., Audero E., Gerber H.P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., and Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 273 (1998) 22128-22135
22. Gotloib L., Wajsbrot V., Shostak A., and Kushnier R. Morphology of the peritoneum: effect of peritoneal dialysis. Perit. Dial. Int. 15 (1995) S9-11 discussion S11-12
23. Ha H., Cha M.K., Choi H.N., and Lee H.B. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit. Dial. Int. 22 (2002) 171-177
24. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?. FEBS Lett. 411 (1997) 157-160
25. Hauglustaine D., van Meerbeek J., Monballyu J., Goddeeris P., Lauwerijns J., and Michielsen P. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD. Clin. Nephrol. 22 (1984) 158-162
26. Itagaki T., Shimizu I., Cheng X., Yuan Y., Oshio A., Tamaki K., Fukuno H., Honda H., Okamura Y., and Ito S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54 (2005) 1782-1789
27. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72 (1992) 449-489
28. Krediet R.T., Zweers M.M., van der Wal A.C., and Struijk D.G. Neoangiogenesis in the peritoneal membrane. Perit. Dial. Int. 20 Suppl 2 (2000) S19-25
29. Mandl-Weber S., Cohen C.D., Haslinger B., Kretzler M., and Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int. 61 (2002) 570-578
30. Margetts P.J., and Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit. Dial. Int. 23 (2003) 530-541
31. Margetts P.J., Kolb M., Yu L., Hoff C.M., and Gauldie J. A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit. Dial. Int. 21 Suppl 3 (2001) S368-372
32. Masuda S., Nagao M., and Sasaki R. Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. Int. J. Hematol. 70 (1999) 1-6
33. Mishima Y., Miyazaki M., Abe K., Ozono Y., Shioshita K., Xia Z., Harada T., Taguchi T., Koji T., and Kohno S. Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Perit. Dial. Int. 23 (2003) 14-22
34. Mortier S., Faict D., Schalkwijk C.G., Lameire N.H., and De Vriese A.S. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int. 66 (2004) 1257-1265
35. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14 (1985) 157-167
36. Nakamoto M. Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes. Perit. Dial. Int. 16 Suppl 1 (1996) S39-41
37. Neben K., Moehler T., Kraemer A., Benner A., Egerer G., Ho A.D., and Goldschmidt H. Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. Br. J. Haematol. 115 (2001) 605-608
38. Nishino T., Miyazaki M., Abe K., Furusu A., Mishima Y., Harada T., Ozono Y., Koji T., and Kohno S. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int. 64 (2003) 887-896
39. Noh H., Kim J.S., Han K.H., Lee G.T., Song J.S., Chung S.H., Jeon J.S., Ha H., and Lee H.B. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int. 69 (2006) 2022-2028
40. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
41. Parsa C.J., Matsumoto A., Kim J., Riel R.U., Pascal L.S., Walton G.B., Thompson R.B., Petrofski J.A., Annex B.H., Stamler J.S., and Koch W.J. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112 (2003) 999-1007
42. Pecoits-Filho R., Araujo M.R., Lindholm B., Stenvinkel P., Abensur H., Romao Jr. J.E., Marcondes M., De Oliveira A.H., and Noronha I.L. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol. Dial. Transplant. 17 (2002) 1480-1486
43. Pollock C. Pathogenesis of peritoneal sclerosis. Int. J. Artif. Organs 28 (2005) 90-96
44. Pollock C.A., Ibels L.S., Eckstein R.P., Graham J.C., Caterson R.J., Mahony J.F., and Sheil A.G. Peritoneal morphology on maintenance dialysis. Am. J. Nephrol. 9 (1989) 198-204
45. Ruetten H., and Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J. Physiol. Pharmacol. 48 (1997) 675-688
46. Sawada T., Ishii Y., Tojimbara T., Nakajima I., Fuchinoue S., and Teraoka S. The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol. Res. 46 (2002) 505-510
47. Sharples E.J., Patel N., Brown P., Stewart K., Mota-Philipe H., Sheaff M., Kieswich J., Allen D., Harwood S., Raftery M., Thiemermann C., and Yaqoob M.M. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 15 (2004) 2115-2124
48. Szabo C., and Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 (1998) 287-298
49. Tahara A., Tsukada J., Tomura Y., Yatsu T., and Shibasaki M. Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells. Pharmacol. Res. 57 (2008) 142-150
50. Tunctan B., Ozveren E., Korkmaz B., Buharalioglu C.K., Tamer L., Degirmenci U., and Atik U. Nitric oxide reverses endotoxin-induced inflammatory hyperalgesia via inhibition of prostacyclin production in mice. Pharmacol. Res. 53 (2006) 177-192
51. Visser C.E., Brouwer-Steenbergen J.J., Struijk G., Krediet R.T., and Beelen R.H. Production of IL-1 beta and TNF-alpha by peritoneal macrophages depends on the bacterial species and the inoculum. Adv. Perit. Dial. 13 (1997) 201-204
52. Williams J.D., Craig K.J., Topley N., Von Ruhland C., Fallon M., Newman G.R., Mackenzie R.K., and Williams G.T. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13 (2002) 470-479
53. Xu B., Dong G.H., Liu H., Wang Y.Q., Wu H.W., and Jing H. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB. Ann. Clin. Lab. Sci. 35 (2005) 161-168
54. Zweers M.M., de Waart D.R., Smit W., Struijk D.G., and Krediet R.T. Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J. Lab. Clin. Med. 134 (1999) 124-132
55. Zweers M.M., Struijk D.G., Smit W., and Krediet R.T. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J. Lab. Clin. Med. 137 (2001) 125-132